During the past decade, Clinica Luganese Moncucco conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Luganese Moncucco" #1 sponsor was "Clinica Luganese Moncucco" with 3 trials, followed by "Swiss Group for Clinical Cancer Research" with 2 trials sponsored, "Dimitri Christoforidis" with 1 trials sponsored, "Oncology Institute of Southern Switzerland" with 1 trials sponsored and "Ricardo Pereira Mestre" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Luganese Moncucco" #1 collaborator was "Cantonal Hospital of St. Gallen" with 1 trials as a collaborator, "Central European Society for Anticancer Drug Research" with 1 trials as a collaborator, "Centre Hospitalier Universitaire Vaudois" with 1 trials as a collaborator, "Clinica Luganese Moncucco" with 1 trials as a collaborator and "Clinical Trial Unit Ente Ospedaliero Cantonale" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Luganese Moncucco" are "BPSD (Behavioral and Psycological Symptoms of Dementia)" (1 trials), "Blood Gas Monitoring, Transcutaneous" (1 trials), "Breast Cancer" (1 trials), "COVID-19" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Clinica Luganese Moncucco" in a lesser frequency.

Most popular intervention types in "Clinica Luganese Moncucco" are "Drug" (4 trials), "Other" (4 trials), "Genetic" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Enoxaparin 40Mg/0.4Ml Inj Syringe 0.4Ml" (1 trials), "Expression of receptors and activating proteases" (1 trials), "Ibrutinib" (1 trials) and "Neoadjuvant chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Luganese Moncucco" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinica Luganese Moncucco". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinica Luganese Moncucco, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Luganese Moncucco, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".